Literature DB >> 25547974

The role of extended pelvic lymphadenectomy with radical prostatectomy for high-risk prostate cancer.

Andrew C Harbin1, Daniel D Eun2.   

Abstract

INTRODUCTION: The role of pelvic lymph node dissection (PLND) during radical prostatectomy (RP) for prostate cancer (PCa) is controversial. Despite extensive research in both patterns of lymphatic drainage and the clinical effect of lymph node involvement, the exact role of PLND in PCa is yet to be defined.
METHODS: A systematic search of the MEDLINE database was performed, and all relevant articles were reviewed in depth.
RESULTS: We included 84 relevant articles in our review and subdivided the information into the following categories: preoperative patient evaluation, procedure/extent of dissection, complications, and robotic surgery era. Most authors agree that the greatest benefit is seen in patients with high-risk PCa undergoing RP. Multiple imaging modalities have been evaluated for assistance in patient selection, but the use of preoperative nomograms appears to be the most helpful selection tool. The role of limited PLND vs. extended PLND (e-PLND) is yet to be defined, though many authors agree that e-PLND is preferred in the setting of high-risk PCa. Although PLND is associated with a higher incidence of complications, especially lymphocele formation, it is unclear whether e-PLND leads to more complications than limited PLND. The introduction of minimally invasive surgery may have had a negative effect on implementation of PLND in the appropriate patients undergoing RP.
CONCLUSION: Despite a lack of prospective, randomized trials evaluating PLND in RP, there does appear to be a consistent benefit in patients with high-risk disease.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Extended pelvic lymph node dissection; High-risk prostate cancer; Radical prostatectomy

Mesh:

Year:  2014        PMID: 25547974     DOI: 10.1016/j.urolonc.2014.11.011

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  7 in total

1.  The impact of extended lymph node dissection versus neoadjuvant therapy with limited lymph node dissection on biochemical recurrence in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysis.

Authors:  Takuma Narita; Takuya Koie; Teppei Ookubo; Koji Mitsuzuka; Shintaro Narita; Hayato Yamamoto; Takamitsu Inoue; Shingo Hatakeyama; Sadafumi Kawamura; Tatsuo Tochigi; Tomonori Habuchi; Yoichi Arai; Chikara Ohyama
Journal:  Med Oncol       Date:  2016-11-26       Impact factor: 3.064

2.  Fluorescence-supported lymphography and extended pelvic lymph node dissection in robot-assisted radical prostatectomy: a prospective, randomized trial.

Authors:  Nina Natascha Harke; Michael Godes; Christian Wagner; Mustapha Addali; Bernhard Fangmeyer; Katarina Urbanova; Boris Hadaschik; Jorn H Witt
Journal:  World J Urol       Date:  2018-05-16       Impact factor: 4.226

3.  Evaluation of Lymphorrhea and Incidence of Lymphoceles: 4DryField® PH in Radical Retropubic Prostatectomy.

Authors:  Johannes-J Karsch; Martin Berthold; Jürgen Breul
Journal:  Adv Urol       Date:  2016-06-23

4.  Identifying the Candidates Who Will Benefit From Extended Pelvic Lymph Node Dissection at Radical Prostatectomy Among Patients With Prostate Cancer.

Authors:  Guanjie Yang; Jun Xie; Yadong Guo; Jing Yuan; Ruiliang Wang; Changcheng Guo; Bo Peng; Xudong Yao; Bin Yang
Journal:  Front Oncol       Date:  2022-01-26       Impact factor: 6.244

5.  Superior metastasis-free survival for patients with high-risk prostate cancer treated with definitive radiation therapy compared to radical prostatectomy: A propensity score-matched analysis.

Authors:  Stephanie Markovina; Marshall W Meeks; Shahed Badiyan; Joel Vetter; Hiram A Gay; Alethea Paradis; Jeff Michalski; Gurdarshan Sandhu
Journal:  Adv Radiat Oncol       Date:  2017-12-13

6.  Can 68Ga-prostate specific membrane antigen positron emission tomography/computerized tomography provide an accurate lymph node staging for patients with medium/high risk prostate cancer? A diagnostic meta-analysis.

Authors:  Lei Peng; Jinze Li; Chunyang Meng; Jinming Li; Chengyu You; Dandan Tang; Tangqiang Wei; Wei Xiong; Yunxiang Li
Journal:  Radiat Oncol       Date:  2020-10-01       Impact factor: 3.481

Review 7.  How molecular imaging will enable robotic precision surgery : The role of artificial intelligence, augmented reality, and navigation.

Authors:  Thomas Wendler; Fijs W B van Leeuwen; Nassir Navab; Matthias N van Oosterom
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-06-29       Impact factor: 9.236

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.